Notice of Appointment of atDose’s COO (2022.5.1)

We are pleased to announce the appointment of Abhijit Deshpande as COO effective May 1, 2022 for further business growth.

Abhijit is originally from Pune, India and has lived in Tokyo for over 20 years and has many years of experience in the pharmaceutical industry and has background in IT.

Joint development and commercialization in Asia is an important mission for the future business development of atDose. I will strive to make most of my past experience and skills for this purpose. by Abhijit, atDose COO.